[DOI] [PubMed] [Google Scholar] 33.Donfrancesco R., Nativio P., Di Benedetto A., Villa M.P., Andriola E., Melegari M.G., Cipriano E., Di Trani M
Here we show that oral intake of long-term oscillating glucose (LOsG) (4 times/day) for 38 days, which produces physiological glycemic variability in rats, can lead to -cells gaining metabolic memory in reactive oxygen species (ROS) stress
Your doctor should patiently answer your questions and relieve your worries
This new research models the potential impact of next-generation weight-loss drugs (like GLP-1RAs) on this very issue
Use of QSYMIA for this indication is supported by a 56-week, double-blind, placebo-controlled study in 223 pediatric patients aged 12 years and above, a pharmacokinetic study in pediatric patients, and studies in adults with obesity [see Clinical Pharmacology (12.3) and Clinical Studies (14)]
Therefore potentially having an impact on your quality of life, as well as potentially helping you to live longer